RSV Vaccine Abrysvo Approved for Individuals 60 Years and Older
Abrysvo is expected to be available in the third quarter of 2023.
Abrysvo is expected to be available in the third quarter of 2023.
The world’s first RSV vaccine could be rolled out by fall 2023, in time for the typical winter surge in RSV infections.
May 18 is HIV Vaccine Day, created to promote awareness of HIV vaccine research. What is the current state of vaccines for preventing HIV and how have recent trials gone?
Arexvy is expected to be available for the 2023-2024 RSV season.
A pediatric infectious disease specialist explains this little-known virus.
Approximately 25% of parents lie about their child’s COVID-19 vaccine status or don’t quarantine their children, survey findings show.
M-M-R II, Varivax, and ProQuad are supplied in single-dose vials as lyophilized vaccine for SC or IM injection after reconstitution.
Vaccine effectiveness 54% against medically attended outpatient acute respiratory infection associated with influenza A in patients younger than 65 years
Several changes have been made to the adult immunization schedule 2023.
Several changes have been made to the child and adolescent immunization schedule for 2023.